GHB, GBL, na 1,4-Butanediol Nfefe na Mwepụ: Nchekwa ụgbọ elu na Ntube ICU¶

Gamma-hydroxybutyrate (** GHB**) na prodrugs kemịkalụ kemịkalụ ya, gamma-butyrolactone (GBL, nke a na-ere ahịa dị ka onye na-ehicha wiilịlụ alloy, paint stripper, ma ọ bụ onye na-ewepụ ntu ntu) na ** 1,4-butanediol *** (** 1,4-BD**, ihe mgbaze ụlọ ọrụ na-eji na polyurethane kachasị na-emepụta ụlọ ọgwụ), anabatara polyurethhal nke na-emepụta ngwa ngwa na ụlọ ọgwụ abụọ. toxicology. Amara na klọb, ememme, chemsex, na okirikiri ahụ dị ka "G", "Liquid Ecstasy", "Fantasy", "Gina", ma ọ bụ "Blue Nitro", mmiri mmiri ndị a doro anya, enweghị isi ma ọ bụ ntakịrị nnu na-enwe ntụzịaka ọgwụgwọ agụba na nrịgo, usoro nzaghachi dose na-abụghị nke linear. N'adịghị ka mmanya na-aba n'anya ma ọ bụ ọgwụ na-enye ọgwụ ọgwụ, ebe ọnụọgụ abụọ na-emepụta ụra nke a na-atụghị anya ya, na-amụba GHB mmiri mmiri ma ọ bụ GBL dose site na naanị ** 0.5 ruo 1.5 milliliters ** na-eme ka metabolism imeju na-eme ka ọ gbanwee ngwa ngwa site na euphoria gaa na-enweghị ike ịgbagha ** Glasgow Coma Scale (GCS) 3 coma **, "Glasgow Coma Scale". N'ime nkeji 15 ruo 45, onye ahụ na-amalite ịda mbà n'obi nke etiti iku ume, Cheyne-Stokes iku ume, bradycardia siri ike (ọnụọgụ obi na-agbada n'okpuru 40 ruo 50 iti kwa nkeji), hypothermia, na vomiting na-apụta mgbe ọ na-enweghị ihe nchebe gag reflex kpamkpam. Nke ka njọ, GHB na GBL n'otu oge na-akpali ndị na-anabata ihe na-akpali akpali nke na-akpalite ime ihe ike ** myoclonic jerks, posturing dystonic, na ọgụ n'oge ntoputa **, na-eduhiekarị ndị na-ege ntị na ndị na-anabata ihe mberede n'ịchọpụta nsogbu hypoxic coma dị ka ihe ọdịdọ mbụ.

Ọbụna dị ize ndụ karịa oke ịdoụbiga mmanya ókè bụ ** nnukwu GHB, GBL, ma ọ bụ 1,4-butanediol withdrawal syndrome **, nke na-eme n'ime ndị mmadụ na-ewere "oge elekere" (ọ bụla awa 1 ruo 3, awa 24 n'ụbọchị) iji zere nchekasị n'etiti dose na-alaghachi azụ. N'ihi na GHB na GBL nwere mkpochapụ plasma dị mkpụmkpụ dị mkpụmkpụ nke naanị **20 ruo nkeji 60 **, enweghị otu dose na-akpalite mwepu nke ukwuu, na-eyi ndụ egwu n'ime awa 1 ruo 6 **. N'adịghị ka mwepu mmanya na-aba n'anya, nke na-arụ ọrụ na $ ederede {GABA}_A $ ndị na-anabata ya ma na-aza amụma maka usoro doses nke diazepam ma ọ bụ lorazepam, nkwụsị GHB na-akpata site na nkwụsị mberede nke inhibitory **\(\text{GABA}_B\) na GHB-kpọmkwem ụda olu nnata **, na-eme ka mgbawa nke etiti na-enweghị mgbawa. Enweghị enyemaka ngwa ngwa ngwa ngwa (ICU) site na iji benzodiazepines intravenous nke ukwuu jikọtara ya na ** baclofen (ntụpọ \(\text{GABA}_B\) agonist), phenobarbital, propofol, ma ọ bụ dexmedetomidine **, mwepu GHB dị ukwuu na-abawanye ngwa ngwa n'ime refractory delirium, hypertherahab na-ada ụda, oke hypertheralysis ọdịda akụrụ, na njide obi na-egbu egbu. Ọ bụrụ na ị chere ihe mberede ihu ugbu a, kpọọ mpaghara gị nọmba mberede ozugbo, ma gakwuru ndị nduzi ụmụnne anyị mmanya na-ewepụ delirium tremens na ọdịdọ, ihe ize ndụ ịdọrọ benzodiazepine, na nlọghachi azụ mgbochi ịdoụbiga mmanya ókè yana naloxone redosing.

Mee nke a ugbu a¶

1. **Nnwale nzaghachi na iku ume ozugbo: ọ bụrụ na onye were GHB, GBL, ma ọ bụ 1,4-butanediol enweghị ike ịkpọte ya site na sternum rub siri ike, na-eri snoring/gurgling, ma ọ bụ na-ewe ihe na-erughị 8 ruo 10 iku ume kwa nkeji, kpọọ nọmba mberede mpaghara gị (911 na US / Canada, 119 na UK, NOW) na UK. "rapu ụra" a G-hole na-eleghị anya; njide iku ume na-egbu egbu na agụụ ịgbachi nkịtị na-eme ngwa ngwa ebe ndị nọ n'akụkụ chere na onye ahụ na-ehi ụra naanị.
2. Tụgharịa onye amaghị ihe ọ bụla n'ime ọnọdụ mgbake aka ekpe ozugbo wee kpochaa vomit a na-ahụ anya n'ọnụ. GHB na GBL na-ejikọta coma miri emi.GCS 3) na mberede, emesis ike (vomiting). Ịdina ala n'azụ na-akpata nkpagbu ozugbo na ọrịa pneumonitis kemịkalụ ka acid afọ na-eju ngụgụ.
3. ** Nlekọta intranasal Naloxone (Narcan 4 mg) wee malite iku ume nnapụta (1 iku ume ọ bụla 5 ruo 6 sekọnd) ma ọ bụrụ na iku ume na-adị nwayọọ, na-emighị emi, ma ọ bụ na-anọghị.* Naloxone na-ewepụ ịda mbà n'obi nke opioid zoro ezo n'enweghị nsogbu ebe iku ume nnapụta na-eme ka ụbụrụ ikuku oxygen ruo mgbe ndị ọrụ ahụike rutere.
4. Etinyela ihe ọ bụla n'ọnụ onye ahụ ma ọ bụ gbochie aka ya ma ọ bụrụ na ị hụ ka ọ na-eme mkpọtụ, na-ama jijiji, ma ọ bụ na-azọpịa ya. Ịṅụbiga mmanya ókè GHB na-ebutekarị ** ihu, ogwe aka, na ogwe osisi na-adịghị na ya n'akụkụ mgbakasị mberede mberede ("ọnọdụ ọkpọ ọkpọ) ma ọ bụ na-egwu mmiri. Mechie isi ha ma chebe ha ka ha ghara ịkụ ngwá ụlọ.
5. ** tụọ ma detuo ụdị ngwaahịa ahụ kpọmkwem (GHB vs. GBL vs. 1,4-BD), olu milliliter ewepụtara, oge nke ikpeazụ dose, na ma onye ahụ na-eji "24/7" (ọ bụla 1 ruo 3 awa gburugburu elekere). iwepụ ozugbo onye ọrịa tetara.
6. ** Na-emeso ịma jijiji ọ bụla, ọsụsọ, obi ịgba ọsọ, paranoia, ma ọ bụ ihe ngosi na-amalite 1 ruo 6 awa mgbe ịkwụsị GHB/GBL mgbe niile dị ka ihe mberede ahụike ICU dị egwu. baclofen ọnụ/enteral na ICU sedation.

Osisi mkpebi: Mfefe oke GHB/GBL ("G-Hole") vs. Nwepu 24/7 na-eyi ndụ egwu.¶

N'ihi na oke ịdoụbiga mmanya ókè na-akpata coma n'ime nkeji ole na ole ebe mwepu na-akpata ọgba aghara n'ime awa ole na ole, ndị nọ n'akụkụ na ndị na-ahụ maka ụlọọgwụ mberede ga-achọpụta ngwa ngwa akụkụ nke ụdị toxicity GHB/GBL na-eme.

flowchart TD
    A["Ihe mberede metụtara GHB, GBL, ma ọ bụ 1,4-Butanediol ('Liquid G')"] --> B{"Kedu ọkwa nke onye ahụ na usoro iheomume kemgbe ọgwụ ikpeazụ ha?"}
    B -->|"Ejiri nkeji 10 ruo elekere 3 gara aga: Ugbu a ụra na-arahụ ụra, na-asọ oyi, enweghị mmasị ('G-Hole'), snoring, twitching, ma ọ bụ vomiting."| C["OGE Mfefe oke: Nnukwu ihe ize ndụ nke Apnea, Aspiration & Bradycardia"]
    B -->|"Onye ọrụ 24/7 na-adịghị ala ala (dose kwa awa 1 ruo 3): Ọgwụ ikpeazụ bụ elekere 1 ruo 12 gara aga; ugbu a na-ama jijiji, ọsụsọ na-agba, na-echegbu onwe ya, tachycardic, ma ọ bụ ihe na-adịghị mma"| D["ỌZỌ KWESỊRỊ OKWU: Ihe ize ndụ dị ukwuu nke Delirium na-eguzogide Benzo na Rhabdomyolysis"]
    C --> E{"Ha nwere ike iteta ma meghee anya ha mgbe a na-agwa ha okwu, na-eku ume nkịtị (> 12 / min)?"}
    E -->|"Mba: Enweghị ike ime mmụọ (GCS <8), iku ume ngwa ngwa/na-eku ume, egbugbere ọnụ na-acha anụnụ anụnụ, obere usu (<50 bpm), ma ọ bụ ịgba agbọ mgbe ọ na-akpụ akpụ"| F["Kpọọ 911 / 112 / 999 ozugbo: 1. Nyefee na ọnọdụ mgbake aka ekpe 2. Nye Naloxone + Napụta ume 3. Kwadebe maka Intubation Airway"]
    E -->|"EE: Teta, na-ekwu okwu nke ọma, iku ume nkịtị, mana isi ọwụwa/ọgbụgbọ"| G["Debe ọdụ ma ọ bụ n'akụkụ ịgha ụgha: Nyochaa iku ume kwa nkeji 3 maka awa 2 (1,4-BD ma ọ bụ GBL nwere ike ịpụ n'oge); kpọọ 911 ma ọ bụrụ na ụra na-emikpu"]
    D --> H{"Ha na-egosi akara akwara ọ bụla ma ọ bụ autonomic (ụjiji, HR> 100 bpm, mkpasu iwe, ehighi ura, mgbagwoju anya, ma ọ bụ paranoia)?"}
    H -->|"EE: Mgbaama mwepu ọ bụla na onye ọrụ elekere elekere (24/7)."| I["Ụlọ ọgwụ ozugbo / ICU mberede: Ụgbọ njem na ED Ugbu a; Ndị dọkịta mara ọkwa ka ha malite usoro Diazepam + Baclofen (GABA-B Agonist) dị elu."]
    H -->|"Mba: Asymptomatic ugbu a, mana ọ na-ewe GHB/GBL> 3 ugboro kwa ụbọchị ma ọ bụ kwa awa 2 ruo 4."| J["Akwụsịla Turkey oyi n'ụlọ: Hazie Detox Medical Inpatient ngwa ngwa na Baclofen + Benzodiazepine Cross-Taper"]

Nkebi 1: Pharmacology nke Razor-Thin Margin (GHB vs. GBL vs. 1,4-Butanediol)¶

Ịghọta ihe kpatara GHB, GBL, na 1,4-butanediol na-akpata nkwụsịtụ mberede na-achọ nyocha otú mmiri atọ ndị a si eme n'ime tract digestive, imeju, na ụbụrụ.

1. Chemical Identity na Metabolic Ntụgharị Ụzọ¶

Ọ bụ ezie na ogige atọ ahụ na-ejupụta ụbụrụ ** gamma-hydroxybutyrate (GHB)**, ike ha kwa milliliter, ọsọ nnabata na mmekọrịta mmanya na-aba n'anya dị iche iche:

1. GHB (Gamma-Hydroxybutyrate / Sodium Oxybate): Acid fatty acid metabolite nke GABA, nke emepụtara n'ụzọ sịntetically site na ime GBL na sodium hydroxide (lye). Ọ na-abụkarị mmiri mmiri doro anya nwere ** nnu, ụtọ ncha ** (\(\text{Na-GHB}\)). Ọ bụrụ na etinyere ya na oke sodium hydroxide n'ụzọ na-ekwesịghị ekwesị.pH > 10 to 12), n'okporo ámá GHB na-ebute oke ** alkaline caustic ọkụ n'ọnụ na esophagus **. Ọ na-eru ọkwa ụbụrụ kachasị elu na nkeji 20 ruo 45 **, yana ọkara ndụ nke **20 ruo 50 nkeji ***.
2. ** GBL (Gamma-Butyrolactone):** Ihe mgbaze lactone cyclic (nke a na-eji na igwe nhicha alloy na ndị na-agba agba) na-arụ ọrụ dị ka ** ngwa ngwa GHB. Ozugbo iloro, plasma ọbara lactonase enzymes (paraoxonase) hydrolyze GBL n'ime GHB n'ime nkeji nkeji . N'ihi na GBL bụ abụba-soluble, ọ na-amịkọrọ ngwa ngwa ( na-arị elu na nkeji 15 ruo 30 **) na ihe fọrọ nke nta ka ọ bụrụ ** 100 pasent bioavailability ọnụ ** (tụnyere 65 pasent maka ọnụ GHB). Milliliter maka milliliter, ** 1.0 ml nke GBL dị ọcha na-ebuga 1.6 ruo 2.0 ugboro karịa GHB na-arụ ọrụ karịa 1.0 ml nke GHB n'okporo ámá **.
3. ** 1,4-Butanediol (1,4-BD / "BDO"):** Ihe mgbaze diol na-emepụta ihe na-eme ka ọ bụrụ ihe siri ike na ** 20 degrees Celsius (68 degrees Fahrenheit) ***. N'adịghị ka GBL, ** 1,4-butanediol chọrọ ntụgharị imeju nzọụkwụ abụọ : nke mbụ site na ** mmanya dehydrogenase (ADH) ** banye gamma-hydroxybutyraldehyde, na nke abụọ site na ** aldehyde dehydrogenase (ALDH) n'ime GHB. N'ihi na ethanol na 1,4-BD na-asọ mpi maka otu imeju ** ADH enzyme **, ịṅụ mmanya na-egbu egbu na-egbochi ntụgharị 1,4-BD ruo mgbe mmanya na-egbu egbu, na-ahapụ oge GHB na-egbu oge.

2. Okpokoro atụnyere: GHB vs. GBL vs. 1,4-Butanediol Clinical Toxicology¶

3. Ihe kpatara usoro nzaghachi dose-nzaghachi ji bụrụ ọnụ ugwu (Zero-Order Saturation Kinetics)¶

N'ime ndị toro eto nwere ahụike, a na-ewepụ GHB site na oxidation na imeju site na ** succinic semialdehyde dehydrogenase (SSADH)** n'ime acid succinic, nke na-abanye na okirikiri Krebs wee na-ekupụ dị ka carbon dioxide na mmiri. Otú ọ dị, ụzọ enzyme imeju nke imeju ** na-ejupụta kpam kpam na mkpokọta ọbara karịa 50 ruo 60 micrograms kwa milliliter ** (ọnụ ụzọ ruru kpọmkwem otu usoro ntụrụndụ).

Ozugbo enzyme imeju ahụ na-ejupụta, mkpochapụ GHB na-esi na ** kinetics nke mbụ ** gaa na ** zero-order kinetics *** (ebe imeju nwere ike ikpochapụ obere ego kwa elekere). N'ihi ya, mgbe ** 1.0 na 1.5 ml nke GBL ** nwere ike ime ka euphoria, ** 2.0 ruo 2.5 mL nke otu karama ahụ kpọmkwem ** (ma ọ bụ imegharị ya na 45 nkeji kama ichere awa 3) na-eme ka ọkwa GHB na-adịghị agwụ agwụ na ụbụrụ ụbụrụ na ** okpukpu atọ ma ọ bụ anọ **, mechie nsụhọ na iku ume.

Nkebi 2: Ijikwa oke ịdoụbiga mmanya ókè ("Ịdaba n'ime oghere G")¶

Mgbe mmadụ were oke GHB/GBL, re-doses n'oge na-adịghị anya ("stacking"), ma ọ bụ gwakọta GHB/GBL na mmanya ** mmanya, benzodiazepines, ketamine, ma ọ bụ opioids ***, ha na-aga n'ihu n'ime nkeji 15 ruo 30 site na usoro ọgwụgwọ anọ:

1. ** Nkeji nke 1 (Ataxia & Okwu Slurred):** Ọsụsọ, enweghị nguzozi, mkpọnwụ, nku anya dị arọ, na ọsụsọ na-agbasi ike.
2. ** Nkeji 2 (Agitated Stupor & Myoclonus):** Na-apụ onwe ya ugboro ugboro, na-eteta n'ụjọ, mgbaka ogwe aka/ihu (myoclonus), ma ọ bụ na-efegharị ogwe aka mgbe e metụrụ ya aka.
3. ** Nkeji nke 3 ("G-Hole" / Coma na-adịghị agwụ agwụ, GCS 3 to 6): *** Mfu nke mmụọ zuru oke; enweghị nzaghachi maka sternum rub; mkpirisi (miosis) ma ọ bụ ụmụ akwụkwọ umengwụ.
4. ** Nkeji 4 (Cardiorespiratory Collapse & Aspiration):** ** Cheyne-Stokes iku ume oge** na nkwụsịtụ nke 15 ruo 30 nkeji nke apnea, ọnụego iku ume n'okpuru ** 6 ruo 8 iku ume kwa nkeji , ** sinus bradycardia (35 to 50 bpm*, hypothermia n'okpuru 35.0 degrees Celsius (95.0 degrees Fahrenheit), na nchikota nke ihe dị n'ime afọ.

1. Gịnị kpatara ịgba agbọ n'ime G-Hole bụ ihe mbụ na-akpata ọnwụ¶

N'adịghị ka ịṅụbiga mmanya ókè nke opioid dị ọcha, ** GHB na GBL na-akpali dopamine na ndị na-anabata emetic na mpaghara postrema n'otu oge ahụ, ha na-ewepụ gag pharyngeal na ụkwara reflexes . Ihe ruru pacenti 30 ruo 50 nke comatose GHB/GBL gabigara ndị ọrịa na-agbọ agbọ mgbe amaghị ihe ọ bụla.GCS 3).

Ọ bụrụ na enyi etinye onye comatose n'azụ ya na sofa ma ọ bụ akwa ka ọ hie ụra, acid afọ na ọdọ mmiri nri na akpịrị wee kunye ya ozugbo n'ime akpa ume abụọ (** ọchịchọ *), na-eme ka ọ kpagbuo ozugbo ma ọ bụ na-egbu egbu ** Mendelson chemical pneumonitis na Acute Respiratory Distress Syndrome (ARDS) awa mgbe e mesịrị.

** Usoro nhazi ọkwa nchekwa ndụ ozugbo:**

1. Tụgharịa onye ahụ n'akụkụ aka ekpe (Left Lateral Recovery Position): Gbatịa ogwe aka ekpe ha n'akụkụ aka nri, gbadaa ikpere aka nri ha n'ala ka ha ghara ịfegharị n'ihu ma ọ bụ azụ, ma tinye aka nri ha n'okpuru ntì aka nri ha.
2. Tụgharịa agba na-aga n'ihu ma mee ka ọnụ ya gbadaa n'ala: Ike ndọda na-agbapụta mmiri ma na-agbọpụta n'ala kama ịgbada trachea ka ọ na-ewepụ ire n'azụ akpịrị.
3. Mụpụta ịsachapụ mkpịsị aka nwere aka ma ọ bụrụ na ọgbụgbọ siri ike a na-ahụ anya na-egbochi ọnụ: Ya adịla mgbe a na-ekpochapụ kpuru ìsì n'ime akpịrị.

2. Gịnị mere GHB ịṅụbiga mmanya ókè ji akpata "Ọnyà adịgboroja" (Myoclonic Jerks & Combativeness)¶

Onye ọrịa GHB/GBL nwere nnukwu nsogbu (GCS 3) na-achita ugboro ugboro, na-amanye aka ha, kụchie agbà ha, ma ọ bụ kụrie ya nke ọma tupu ọ daa azụ n'ime jụụ. Obere mkpokọta nke GHB na-akpali excitatory presynaptic ** GHB ndị na-anabata ya ** ma na-akpaghasị sekit thalamic-cortical (na-emepụta ** myoclonus ), ebe nnukwu mkpokọta na-akpali inhibitory $ ederede{GABA}_B$ receptors. Ka ụbụrụ ụbụrụ na-agafe n'ọnụ ụzọ a, onye ahụ na-enweta ahụmahụ ** multifocal myoclonic jerks ** na ** emergence delirium ("G-fight").

Ejila onye ahụ ala n'azụ, ** etinyela ihe n'etiti ezé ha, yana ** ndị na-ahụ maka ahụike na-ahụ maka nje ahụ sitere na GHB/GBL toxicity **. N'ụlọ ọgwụ, ndị dọkịta na-ahụ maka mberede na-ezere ibufe onye ọrịa GHB na-enweghị ọgwụ na benzodiazepines intravenous maka twitches myoclonic na-adịghị mma, n'ihi na ịgbakwunye diazepam ma ọ bụ lorazepam n'elu GHB nwere ike gbanwee iku ume n'ókè n'ime njide iku ume zuru oke.

3. "Lazarọs edemede" na ihe kpatara na ndị ọrịa ekwesịghị ịpụ na ER n'oge¶

N'ime oke GHB ma ọ bụ GBL na-enweghị mgbagwoju anya, ozugbo imeju kpochapụrụ ọgwụ zuru oke (nke na-abụkarị ** 2 ruo 5 awa ** mgbe ọ risịrị nri), onye ọrịa na-enweta "Lazarọs mmetụta": n'ime ** 10 ruo 15 nkeji **, onye ọrịa na-ama jijijiGCS 3) na mberede meghere anya ha, na-amụ anya (GCS 15), ma rịọ ka ọ laa. Ịhapụ ụlọ ọgwụ ozugbo dị ize ndụ n'ihi ihe atọ:

1. ** Ntugharị 1,4-Butanediol + mmanya na-egbu egbu: ** Mgbanwe nke abụọ nke ntụgharị GHB nwere ike ịda ma ọ bụrụ na 1,4-BD enweghị metabolized na-anọgide na imeju.
2. ** Ọchịchọ Silent Pneumonitis:** Ndị ọrịa na-agbọ agbọ mgbe ha na-achọ ihe nleba anya saturation oxygen awa 6 na onyonyo obi iji wepụ mmerụ ahụ nku ume na-apụta.
3. ** Bọmbụ oge mwepụ nke 24/7:** Maka ndị ọrụ elekere anya dabere, iteta site na ịdoụbiga mmanya ókè pụtara ọkwa GHB ọbara ruru efu; n'ime nkeji 60 ruo 180 ***, ha nwere ike ịbanye n'ime nnukwu nkwụsị nke GHB.

Akụkụ 3: Ọrịa GHB / GBL / 1,4-BD na-eyi ndụ egwu.¶

Ọ bụ ezie na nnukwu "G-hole" nwere ike igbu n'ime nkeji 30 site na nkwụsị ụgbọ elu, ** nnukwu GHB / GBL nkwụsị bụ ogologo oge, nsogbu ahụike hyper-metabolic nke na-ebu ọnụ ọgụgụ ọnwụ edekọtara na mmanya Delirium Tremens (DTs) na-adịghị agwọ ọrịa, ma na-etolite ** anọ ruo ugboro asatọ ngwa ngwa **.

1. Onye nọ n'ihe ize ndụ maka ịwepụ siri ike? (The "24/7" Dosing Trap)¶

N'ihi na GHB na GBL na-agwụcha kpamkpam n'ime awa 2 ruo 3, ndị ọrụ oge niile na-achọpụta ngwa ngwa na ka ọgwụ ọ bụla na-ebelata, ha na-enweta mmụba nke dopamine na glutamate ** ("G-rebound"): na-eteta n'elekere 3:00 nke ụtụtụ na obi ịgba ọsọ, ụra nke ukwuu, ụjọ na ọsụsọ. Iji hie ụra abalị ma na-arụ ọrụ n'ehihie, onye ahụ na-amalite doses ** kwa awa 1.5 ruo 3 gburugburu elekere ("24/7 dosing").

** Ebe mgbaba ọkọlọtọ na-acha ọbara ọbara maka ahụike siri ike nke anụ ahụ:**

• ** Ugboro ugboro:** Inweta GHB, GBL, ma ọ bụ 1,4-butanediol ** karịa 4 ruo 6 ugboro kwa ụbọchị , ma ọ bụ ** awa 1 ruo 4 ọ bụla gburugburu elekere (gụnyere iteta n'ụra n'abalị iji were “ụgwọ ụra”) maka obere ihe dị ka ** 2 ruo 4 izu anọ.
• Mkpokọta mpịakọta kwa ụbọchị: *** Na-eri ihe karịrị gram 15 ruo 25 nke GHB kwa ụbọchị ** ma ọ bụ karịa ** 10 ruo 15 milliliters nke GBL ma ọ bụ 1,4-BD kwa ụbọchị *** (ndị ọrụ 24/7 siri ike na-erikarị. 30 to 80+ mL GBL kwa ụbọchị).

2. Usoro iheomume nke elekere-site-hour nke nnukwu GHB / GBL iwepụ¶

N'ihi na ọkara ndụ plasma nke GHB dị n'okpuru nkeji 60, nkwụsị na-amalite ** tupu onye ahụ ahapụ ụlọ mberede ma ọ bụ ụgbọ elu ***:

3. Ihe kpatara iwepụ GHB ji bụrụ "Benzodiazepine-Resistant" (Na Ihe kpatara Baclofen ji azọpụta ndụ)¶

Mgbe onye ọrịa na-ewepụ mmanya na-aba n'anya bịarutere n'ụlọ ọgwụ, ** diazepam ma ọ bụ lorazepam*** na-akpalite \(\text{GABA}_A\) chloride channels, dochie mmetụta mgbochi mmanya. N'ụzọ dị iche, GHB, GBL, na 1,4-butanediol na-eme ihe bụ isi na metabotropic \(\text{GABA}_B\) receptors na GHB receptors, na-eme ihe na-adịghị mma na \(\ ederede{GABA}_A\) ndị na-anabata ya na ụdị doses. N'ime onye ọrụ 24/7 na-adịghị ala ala, \(\text{GABA}_B\) na-agbadata nke ukwuu; mgbe GHB kwụsịrị, presynaptic glutamate na dopamine neurons na-agba ọkụ na-enweghị nchịkwa n'ihi na breeki **\(\text{GABA}_B\) na-efunahụ ***.

Inye usoro onunu ogwu nke benzodiazepine (nke na-akpali naanị \(\ ederede{GABA}_A\) ndị na-anabata ya) anaghị akwụsịkarị nkwụsi ike a: ** ndị ọrịa na-ewepụ nnukwu GHB chọrọ 200 ruo 500+ milligrams nke diazepam intravenous kwa awa 24*** ma ka na-ata ahụhụ nhụsianya delirium belụsọ ma ọ bụrụ na ABA na-enweta nsonaazụ nhụsianya. (** baclofen**) ma ọ bụ ** phenobarbital/propofol** na-agbakwunye.

4. Okpokoro atụnyere: Mwepụ mmanya na-aba n'anya vs. Benzodiazepine mwepụ vs. GHB/GBL mwepụ¶

Akụkụ 4: Mbelata-Mbelata Pipette Dosing & Mgbochi Ịṅụbiga mmanya ókè na mberede¶

Ihe fọrọ nke nta ka ọ bụrụ 100 pasent nke ịdoụbiga mmanya ókè GHB/GBL na-egbu egbu na-esite na njehie anọ nwere ike igbochi: iji okpu karama tụọ sirinji akara, ịgwakọta mmanya na-egbu egbu ma ọ bụ ihe na-eme ka ahụ sie ike, megharịa ọgwụ tupu ọgwụ mbụ ekpochapụ, ma ọ bụ ịṅụ mmiri na karama mmiri a na-edeghị aha.

+-------------------------------------------------------------------------+
|       THE 4 LIFE-SAVING GHB / GBL HARM-REDUCTION RULES                  |
|                                                                         |
|  1. MEASURE EVERY DOSE TO 0.1 mL WITH A 1 mL ORAL BARREL SYRINGE:       |
|     NEVER pour into a bottle cap or cup. A standard water-bottle cap    |
|     holds 5 to 7 mL (up to 3x a lethal coma dose of GBL).               |
|                                                                         |
|  2. DYE AND LABEL EVERY CONTAINER IMMEDIATELY:                          |
|     NEVER store GHB, GBL, or 1,4-BD in a clear drinking water bottle.   |
|     Add blue food coloring and wrap a warning label around the bottle.  |
|                                                                         |
|  3. SET A STRICT 2.5 TO 3 HOUR TIMER ON YOUR PHONE BEFORE RE-DOSING:    |
|     Log your exact mL dose and timestamp on your phone screen. Never    |
|     take a booster dose inside 2 hours.                                 |
|                                                                         |
|  4. ZERO ALCOHOL, ZERO KETAMINE, ZERO BENZOS, ZERO OPIOIDS:             |
|     Even ONE beer or shot mixed with GHB/GBL multiplies respiratory     |
|     arrest risk, and alcohol + 1,4-BD creates a delayed liver bomb.     |
+-------------------------------------------------------------------------+

Ihe kpatara na ị gaghị anwale ụlọ na-enweghị nlekọta site na iji 24/7 GBL¶

Mgbe mmadụ matara na ha tọrọ atọ n'ụzọ anụ ahụ na 24/7 GHB/GBL dosing (na-eteta kwa nkeji 90 ruo 120 iji mee ihe), ịgbalị ịkwụsị turkey oyi n'ụlọ ma ọ bụ iji ọgwụ mgbochi Xanax na-agwọ onwe ya ma ọ bụ mmanya na-egbu ndụ:

• ** Ihe kpatara oyi Turkey ji ada: *** N'ime awa 3 ruo 6 nke nkwụsị, oke ịma jijiji, ọgbụgbọ, na mgbagwoju anya na-etolite; Site na elekere 12 ruo 24, nnukwu paranoid delirium na-ewepụ ikike ịkpọ ụgbọ ihe mberede.
• ** Ihe kpatara mmanya na-aba n'anya ma ọ bụ okporo ámá Benzodiazepines ji egbu: *** Ịṅụ mmanya n'elu GHB/1,4-BD ma ọ bụ na-ewere ụzọ adịgboroja alprazolam (nke a na-ejikarị ** fentanyl ma ọ bụ bromazolam**) na-akpata njide iku ume na-akwụsịghị \(\ ederede{GABA}_B\) delirium.

• ** Akwa akwa nchekwa ruo mgbe nnabata ụlọ ọgwụ:** Ntuziaka ọgwụ riri ahụ (** UK NEPTUNE na Dutch NISPA *) ndụmọdụ ** akwụsịghị mmezi mmezi na mberede n'ụlọ n'abalị tupu nnabata. Gaa ozugbo gaa na Ngalaba Mberede ma ọ bụ ụlọ ọrụ detox inpatient ** tupu iwepụ delirium amalite **, na-ebute akwụkwọ dosing gị na karama ka ndị dọkịta nwee ike ibido usoro mgbanwe ** Baclofen + Diazepam mgbanwe ** n'okpuru obi na Creatine Kinase (CK) nlekota oru.

• (Ọ bụrụ na gị ma ọ bụ onye ị hụrụ n'anya na-alụ ọgụ na GHB, GBL, ma ọ bụ ịdabere na polysubstance, lee Iji ihe na ọgwụ riri ahụ: ntuziaka enyemaka mberede na Ịkwado onye òtù ezinụlọ na-eri ahụ. Onye ọ bụla nke na-aga ihe omume abalị ma ọ bụ na-akwado onye nọ n'ihe ize ndụ kwesịrị imezu ihe enyemaka mbụ na nkwado ndụ site na Red Cross, St John Ambulance, ma ọ bụ onye na-enye ọzụzụ mpaghara.)*

Nọmba mberede mpaghara na ụkpụrụ ụlọ ọrụ¶

Mgbe ị na-akpọ maka ụgbọ ihe mberede ma ọ bụ ebe nchịkwa nsị n'oge mberede GHB, GBL, ma ọ bụ 1,4-butanediol, kwupụta nke ọma ma onye ọrịa nọ na ** nnukwu ihe na-adịghị mma ("G-hole" / nkụda mmụọ iku ume) ** ma ọ bụ ** nnukwu 24/7 nkwụsị delirium **.

Ajụjụ a na-ajụkarị¶

Ntuziaka emetụtara¶

• Mwepụ mmanya na-aba n'anya, delirium tremens, ọdịdọ, na nhụsianya detox ahụike
• Ihe ize ndụ mwepu nke Benzodiazepine na nkwụsi ike mberede
• Ịṅụbiga mmanya ókè na-akpali akpali ('overamping'): hyperthermia, mgbu obi, na mgbakasị ahụ.
• Nlaghachi azụ na mgbochi ịdoụbiga mmanya ókè: fentanyl/xylazine test ibe na naloxone
• Iji ihe na ọgwụ riri ahụ: ntuziaka enyemaka mberede
• Nọmba mberede

Isi mmalite na nduzi ọchịchị¶

• ** European Union Drugs Agency (EUDA / mbụ EMCDDA) & Radboud University Nijmegen Medical Center (NISPA, Netherlands): ** * GHB, GBL na 1,4-BD: Pharmacokinetics, Nnukwu nchịkwa nchịkwa, na Detoxification Protocols Iji Pharmaceutical GHB na Baclofen *.
• ** Novel Psychoactive Treatment UK Network (NEPTUNE) & UK National Poisons Information Service (TOXBASE):** Ntuziaka na Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances: GHB na GBL.
• ** Òtù Ahụ Ike Ụwa (WHO) Ndị ọkachamara na-ahụ maka ịdabere na ọgwụ ọjọọ (ECDD): *** * Akụkọ nyocha dị mkpa na Gamma-Hydroxybutyric Acid (GHB), Gamma-Butyrolactone (GBL), na 1,4-Butanediol (1,4-BD)*.
• ** American Society of Addiction Medicine (ASAM) & American College of Medical Toxicology (ACMT):** * Ntuziaka nlekọta ahụike na njikwa nke Sedative, Hypnotic, ma ọ bụ Anxiolytic iwepụ (gụnyere GHB/GBL Benzodiazepine-Resistant Withdrawal Delirium, Baclofen Adjunctive Therapy) Ph.
• Mmegbu ihe na nchịkwa ahụike uche (SAMHSA) & National Institute on Drug Abuse (NIDA / NIH, United States): Club Drugs and Central Nevous System Depressant overdose and withdrawal Triage.